Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

COX-2 inhibitor reduces skeletal muscle hypertrophy in mice.

Novak ML, Billich W, Smith SM, Sukhija KB, McLoughlin TJ, Hornberger TA, Koh TJ.

Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1132-9. doi: 10.1152/ajpregu.90874.2008. Epub 2009 Jan 28.

2.

Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice.

DiPasquale DM, Cheng M, Billich W, Huang SA, van Rooijen N, Hornberger TA, Koh TJ.

Am J Physiol Cell Physiol. 2007 Oct;293(4):C1278-85. Epub 2007 Jul 25.

3.

Hypoxia transiently affects skeletal muscle hypertrophy in a functional overload model.

Chaillou T, Koulmann N, Simler N, Meunier A, Serrurier B, Chapot R, Peinnequin A, Beaudry M, Bigard X.

Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R643-54. doi: 10.1152/ajpregu.00262.2011. Epub 2011 Dec 21.

4.

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.

Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ.

Am J Physiol Cell Physiol. 2009 Jun;296(6):C1258-70. doi: 10.1152/ajpcell.00105.2009. Epub 2009 Apr 8.

5.

Vitamin C administration attenuates overload-induced skeletal muscle hypertrophy in rats.

Makanae Y, Kawada S, Sasaki K, Nakazato K, Ishii N.

Acta Physiol (Oxf). 2013 May;208(1):57-65. doi: 10.1111/apha.12042. Epub 2013 Jan 28.

PMID:
23181439
6.

Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice.

Bae SK, Cha HN, Ju TJ, Kim YW, Kim HS, Kim YD, Dan JM, Kim JY, Kim SD, Park SY.

J Appl Physiol (1985). 2012 Jul;113(1):114-23. doi: 10.1152/japplphysiol.00431.2011. Epub 2012 Apr 19.

7.

Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.

Ching JK, Luebbert SH, Collins RL 4th, Zhang Z, Marupudi N, Banerjee S, Hurd RD, Ralston L, Fisher JS.

Exp Physiol. 2013 Feb;98(2):526-35. doi: 10.1113/expphysiol.2012.066357. Epub 2012 Aug 31.

8.

A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo.

Shavlakadze T, Chai J, Maley K, Cozens G, Grounds G, Winn N, Rosenthal N, Grounds MD.

J Cell Sci. 2010 Mar 15;123(Pt 6):960-71. doi: 10.1242/jcs.061119. Epub 2010 Feb 23. Erratum in: J Cell Sci. 2013 Oct 1;126(Pt 19):4536.

9.

Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.

Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP.

J Physiol. 2006 Nov 1;576(Pt 3):923-33. Epub 2006 Aug 17.

10.

A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy.

Spangenburg EE, Le Roith D, Ward CW, Bodine SC.

J Physiol. 2008 Jan 1;586(1):283-91. Epub 2007 Nov 1.

11.
12.

Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy.

Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Pende M, Daegelen D, Sakamoto K, Foretz M, Viollet B.

FASEB J. 2009 Jul;23(7):2264-73. doi: 10.1096/fj.08-119057. Epub 2009 Feb 23.

13.

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.

Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P.

J Clin Invest. 2005 Feb;115(2):451-8.

14.

Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.

Ferey JL, Brault JJ, Smith CA, Witczak CA.

Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E686-94. doi: 10.1152/ajpendo.00322.2014. Epub 2014 Aug 26.

15.

Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.

Sandri M, Barberi L, Bijlsma AY, Blaauw B, Dyar KA, Milan G, Mammucari C, Meskers CG, Pallafacchina G, Paoli A, Pion D, Roceri M, Romanello V, Serrano AL, Toniolo L, Larsson L, Maier AB, Muñoz-Cánoves P, Musarò A, Pende M, Reggiani C, Rizzuto R, Schiaffino S.

Biogerontology. 2013 Jun;14(3):303-23. doi: 10.1007/s10522-013-9432-9. Epub 2013 May 19.

PMID:
23686362
16.

NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.

Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.

J Am Coll Surg. 2004 Sep;199(3):428-35.

PMID:
15325613
17.

Smad2 and 3 transcription factors control muscle mass in adulthood.

Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, Sandri M.

Am J Physiol Cell Physiol. 2009 Jun;296(6):C1248-57. doi: 10.1152/ajpcell.00104.2009. Epub 2009 Apr 8.

18.

The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.

Kalista S, Schakman O, Gilson H, Lause P, Demeulder B, Bertrand L, Pende M, Thissen JP.

Endocrinology. 2012 Jan;153(1):241-53. doi: 10.1210/en.2011-1687. Epub 2011 Nov 15.

PMID:
22087027
19.

Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy.

Basualto-Alarcón C, Jorquera G, Altamirano F, Jaimovich E, Estrada M.

Med Sci Sports Exerc. 2013 Sep;45(9):1712-20. doi: 10.1249/MSS.0b013e31828cf5f3.

PMID:
23470307
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk